Current in-vitro 2D cultures and animal models present severe limitations in recapitulating
human physiopathology with striking discrepancies in estimating drug efficacy and side …

Nanotechnology‐based approaches are promising for the treatment of musculoskeletal
(MSK) disorders, which present significant clinical burdens and challenges, but their clinical …

Monkeypox virus (MPXV) poses a global health emergency, necessitating rapid, simple, and
accurate detection to manage its spread effectively. The Clustered Regularly Interspaced …

Biological barriers are multicellular structures that precisely regulate the transport of ions,
biomolecules, drugs, cells, and other organisms. Transendothelial/epithelial electrical …

The inefficiency of existing animal models to precisely predict human pharmacological
effects is the root reason for drug development failure. Microphysiological system/organ-on …

Mortality from liver disease conditions continues to be very high. As liver diseases manifest
and progress silently, prompt measures after diagnosis are essential in the treatment of …

Abstract Organs-on-chips (OoCs) are in vitro models that simulate the anatomical and
physiological structure of human organs at the micro-scale level. With the advantages of …

There is an increasing need for better preclinical therapeutic development models suitable
for the human body. As a result, there has been a shift from traditional animal models to …

Cancer is considered a pandemic, costing precious lives throughout the globe. Besides its
deadly outcomes, the survival rate after cancer therapies is meager. Anti-cancer drug …

Sensing devices have shown tremendous potential for monitoring state-of-the-art organ chip
devices. However, challenges like miniaturization while maintaining higher performance …